SCHEMBL29367337

SCHEMBL29367337

C=CC(=O)Nc1ccc2c(c1)C(Oc1cc(F)cc(F)c1)CC2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TGM2 P21980 10/20 0.44
▸ MTNR1A P48039 1/20 0.38
▸ BLK P51451 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ F13A1 P00488 3/20 0.37
▸ TGM1 P22735 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ GSTO1 P78417 1/20 0.37
▸ BRD4 O60885 2/20 0.36
▸ EGFR P00533 2/20 0.36
▸ BRAF P15056 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TGM3 Q08188 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK13 Q14004 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28997043 0.91 TGM2 (0.50) TGM2MTNR1ANPC1RAB9AGSTO1
SCHEMBL28997004 0.90 TGM2 (0.41) TGM2BTKNPC1RAB9AEGFR
SCHEMBL29366852 0.90 TGM2 (0.41) TGM2BTKNPC1RAB9AEGFR
SCHEMBL29369906 0.87 TGM2 (0.42) TGM2MTNR1ABTKF13A1TGM1
SCHEMBL28996985 0.86 TGM2 (0.50) TGM2MTNR1ABTKEGFR
SCHEMBL28996940 0.84 TGM2 (0.44) TGM2MTNR1ANPC1RAB9AGSTO1
SCHEMBL28997537 0.84 TGM2 (0.53) TGM2BRAFKDR
SCHEMBL28996914 0.84 TGM2 (0.53) TGM2BRAFKDR
SCHEMBL28997076 0.84 BRD4 (0.46) TGM2NPC1RAB9ABRD4EGFR
SCHEMBL26124319 0.84 TGM2 (0.53) TGM2BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4188907-A1 ACRYLAMIDE-SUBSTITUTED INDANE COMPOUNDS AND THERAPEUTIC USE THEREOF SANOFI (FR) 2023-06-07 — — EP disclosed
WO-2022023460-A1 ACRYLAMIDE-SUBSTITUTED INDANE COMPOUNDS AND THERAPEUTIC USE THEREOF SANOFI (FR) 2022-02-03 — — WO disclosed
Send feedback